Hidyanara L. de Paula, RN; Carlos D. F. de Souza, PhD; Sara R. Silva, RN; et al.
free access
JAMA Dermatol. 2019;155(10):1120-1128. doi:10.1001/jamadermatol.2019.1768
This systematic review and meta-analysis of 32 studies assesses the strength of evidence linking clinical features and sex of patients with leprosy to disability.
Kristina Gorbatenko-Roth, PhD, LP; Neil Prose, MD; Roopal V. Kundu, MD; et al.
free access
has audio
JAMA Dermatol. 2019;155(10):1129-1134. doi:10.1001/jamadermatol.2019.2063
This cross-sectional study explores black patients鈥� perceptions of their dermatology experience both in and outside of skin of color clinic settings.
-
Podcast:
Assessment of Black Patients鈥� Perception of Their Dermatology Care
Julia K. Winkler, MD; Christine Fink, MD; Ferdinand Toberer, MD; et al.
free access
JAMA Dermatol. 2019;155(10):1135-1141. doi:10.1001/jamadermatol.2019.1735
This cross-sectional study investigates the association of surgical skin markings in dermoscopic images with the diagnostic performance of a deep learning convolutional neural network in 3 image sets of 130 melanocytic lesions each.
Erica D. Dommasch, MD, MPH; Seoyoung C. Kim, MD, ScD, MSCE; Moa P. Lee, PharmD, MPH; et al.
free access
JAMA Dermatol. 2019;155(10):1142-1152. doi:10.1001/jamadermatol.2019.1121
This cohort study compares the risk of serious infection associated with biologic and nonbiologic systemic medications in patients with psoriasis.
Tadashi Terui, MD, PhD; Satomi Kobayashi, MD, PhD; Yukari Okubo, MD, PhD; et al.
open access
JAMA Dermatol. 2019;155(10):1153-1161. doi:10.1001/jamadermatol.2019.1394
This randomized clinical trial evaluates the efficacy and safety of guselkumab in the treatment of patients with palmoplantar pustulosis.
Sean Singer, BS; Elizabeth Tkachenko, BS; Priyank Sharma, MD; et al.
free access
JAMA Dermatol. 2019;155(10):1162-1166. doi:10.1001/jamadermatol.2019.1416
This study evaluates types and frequency of psychiatric adverse events that were reported to the US Food and Drug Administration鈥檚 Adverse Event Reporting System from 1997 through 2017 for patients taking isotretinoin.
Kelly C. Nelson, MD; Susan M. Swetter, MD; Kathylynn Saboda, MS; et al.
free access
JAMA Dermatol. 2019;155(10):1167-1174. doi:10.1001/jamadermatol.2019.1514
This systematic review and meta-analysis evaluates the worldwide variations in the number-needed-to-biopsy (NNB) metric, lack of related data on US-based dermatologists, and nonstandardized processes for reporting NNB for diagnosing cutaneous melanoma.